NYSE · BCSF
Bain Capital Specialty Finance financials
$11.23+0.90%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $250.4M | $277.4M | $279.5M | $222.3M | $229.5M | $194.5M |
| Gross profit | $169.8M | $202.7M | $199.5M | $170.0M | $178.1M | $131.2M |
| Gross margin | 67.8% | 73.1% | 71.4% | 76.5% | 77.6% | 67.4% |
| Operating income | $102.5M | $123.9M | $126.7M | $106.3M | $119.9M | $86.1M |
| Net income | $98.8M | $119.4M | $123.4M | $105.5M | $119.8M | $85.8M |
| Net margin | 39.4% | 43.0% | 44.1% | 47.4% | 52.2% | 44.1% |
| Diluted EPS | $1.53 | $1.85 | $1.91 | $1.63 | $1.86 | $1.46 |
| EBITDA | $102.5M | $123.9M | $126.7M | $106.3M | $119.9M | $86.1M |
| Operating cash flow | $29.5M | -$27.1M | $219.3M | -$316.8M | $265.6M | $89.4M |
| Free cash flow | $29.5M | -$27.1M | $219.3M | -$316.8M | $265.6M | $89.4M |
| Diluted shares | 64.8M | 64.6M | 64.6M | 64.6M | 64.6M | 58.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $26.2M | $53.5M | $49.4M | $59.8M | $117.4M |
| Short-term investments | $2.54B | $2.48B | $2.36B | $2.45B | $2.38B |
| Total debt | $1.47B | $1.39B | $1.26B | $1.39B | $1.41B |
| Total assets | $2.66B | $2.63B | $2.47B | $2.59B | $2.57B |
| Total liabilities | $1.55B | $1.49B | $1.34B | $1.48B | $1.47B |
| Shareholders' equity | $1.12B | $1.14B | $1.14B | $1.12B | $1.10B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology